Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
The Yamuna Syndicate
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.78 % | 1.16 % | 9.02 % |
|
5yr average Equity Multiplier
|
2.69 | 1.02 | 1.0 |
|
5yr Average Asset Turnover Ratio
|
1.34 | 0.01 | 0.06 |
|
5yr Avg Net Profit Margin
|
12.12 % | 2029.38 % | 160.64 % |
|
Price to Book
|
0.0 | 0.39 | 0.92 |
|
P/E
|
38.2 | 0.0 | 10.86 |
|
5yr Avg Cash Conversion Cycle
|
62.15 Days | -3.66 Days | 59.87 Days |
|
Inventory Days
|
29.3 Days | 33.27 Days | 32.28 Days |
|
Days Receivable
|
196.63 Days | 0.0 | 21.24 Days |
|
Days Payable
|
131.74 Days | 93.13 Days | 4.48 Days |
|
5yr Average Interest Coverage Ratio
|
52.6 | 0.76 | 1839.15 |
|
5yr Avg ROCE
|
46.86 % | 1.14 % | 0.55 % |
|
5yr Avg Operating Profit Margin
|
14.35 % | -165.57 % | 2.66 % |
|
5 yr average Debt to Equity
|
0.17 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
83.69 % | -59.1 % | -0.17 % |
|
5yr Average Return on Assets
|
16.02 % | 1.14 % | 9.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.85 % | 73.79 % | 74.87 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.24 % | 0.01 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
The Yamuna Syndicate
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|